Earnings Intelligence
Insight-rich articles built from earnings calls.
Stay ahead with how businesses evolve.
High-Value Insights
Articles with exceptional investment signal
Maze Therapeutics (MAZE) Q4 2025: MZE829 Delivers 36% UACR Reduction, Unlocking Broad AMKD Proof-of-Concept
Maze Therapeutics demonstrates a disruptive model with a long runway, high returns, and strong clinical momentum. The business is not yet showing >40% revenue/earnings growth...
Selcuity (CELC) Q4 2025: R&D Spend Climbs 40% as Getatilicib Nears $5B Market Opportunity
Selcuity is at a binary inflection with a potentially transformative drug, a large addressable market, and imminent regulatory and data catalysts. The business model is...
PGEN Q4 2025: Pepsimios Launch Drives 149% Revenue Surge, RRP Market Adoption Accelerates
PGEN demonstrates a rare, high-signal commercial inflection: rapid revenue growth, improving unit economics, broadening market opportunity, and strong customer adoption. The...
HIT Q4 2025: Distribution Network Expands 34%, Unlocking Underpenetrated Self-Funded Health Market
HIT demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and compounding self-reinforcing advantages. The company has posted very...
KRMN Q4 2025: Backlog Surges 38% to $801M as Defense Demand Accelerates
KRMN demonstrates a long reinvestment runway with high ROIC, a massive surge in backlog (+38%), clear improvements in unit economics, and a self-reinforcing business model...
GCT Semiconductor (GCTS) Q4 2025: 76% Sequential Revenue Surge Signals Early 5G Ramp
GCT is at a pivotal inflection with early 5G commercialization, strong sequential revenue growth, and expanding customer/vertical opportunities via satellite and IoT...
Cognite (CGNT) Q4 2026: Gross Margin Hits 74.7% as Subscription Mix and AI Tailwinds Deepen
Cognite demonstrates a long reinvestment runway, improving unit economics, and a self-reinforcing business model with high recurring revenue and strong margin expansion....
EDAP (EDAP) Q4 2025: HIFU Revenue Climbs 34% as U.S. Adoption Accelerates Platform Shift
EDAP is demonstrating a long reinvestment runway, disruptive business model, rapidly accelerating growth in its HIFU business, improving unit economics, and clear recurring...
Top Articles
- Oracle (ORCL) Q4 2025: Cloud Acceleration and AI-Driven Demand Push Revenue and Guidance to New Highs
- TSMC (TSM) Q1 2025: AI Demand and Global Expansion Drive 38% Growth Outlook, Margin Dilution in Focus
- Novo Nordisk (NVO) Q1 2025: Strong 18% Growth as GLP-1 Compounding Clouds U.S. Outlook
- Meta (META) Q1 2025: AI Investment Drives Revenue Growth, Margins Hold as CapEx Surges
- Walmart (WMT) Q1 2026 Earnings: E-commerce Profitability Milestone Amidst Tariff Headwinds
Recent Earnings
- SanuWave (SNWV) Q4 2025: Applicator Revenue Hits $6.8M, Channel Realignment Accelerates Post-CMS Shift
- XYF (XYF) Q4 2025: Loan Volume Drops 29% as Regulatory Clampdown Spurs Cautious Reset
- Rockwell Medical (RMTI) Q4 2025: Gross Margin Jumps to 21% on Customer Diversification and Supply Chain Gains
- Acumen (ABOS) Q4 2025: EBD Platform Spurs $36M Raise as Brain Penetration Hits 40X in Preclinical
- MillerKnoll (MLKN) Q3 2026: Retail Orders Up 7.9% as Store Expansion Reshapes Growth Profile
- MDV Q4 2025: $7M+ Asset Dispositions Set Stage for Portfolio Purification
- WidePoint (WYY) Q4 2025: Commercial Revenue Rises 6% as DAS Model Drives Margin Expansion
- PGEN Q4 2025: Pepsimios Launch Drives 149% Revenue Surge, RRP Market Adoption Accelerates
Technology
- WYY: Commercial Revenue Rises 6% as DAS Model Drives Margin Expansion
- GCTS: 76% Sequential Revenue Surge Signals Early 5G Ramp
- PAYX: Paycor Integration Drives 20% Revenue Surge, Cross-Sell Momentum Builds
- CGNT: Gross Margin Hits 74.7% as Subscription Mix and AI Tailwinds Deepen
- ONDS: Acquisition-Driven 629% Revenue Surge Signals Multi-Domain Defense Platform Inflection
- PAYS: Patient Affordability Revenue Jumps 168%, Unlocking Operating Leverage Inflection
Communication Services
Make Better Investment Decisions
Decode earnings calls with AI-powered analysis.
Spot trends before the market catches on.
Newsworthy Companies
- Nvidia (NVDA): Record Data Center Revenue Signals Accelerating AI Infrastructure Build-out
- JPMorgan Chase (JPM): Investment Banking Rebounds While Consumer Division Navigates Changing Rate Environment
- Johnson & Johnson (JNJ): Pipeline Advancements Offset by Litigation Concerns in Quarterly Guidance
- Microsoft (MSFT): Azure Growth Accelerates as Enterprise AI Adoption Gains Momentum
- Apple (AAPL): Services Revenue Hits New Record While iPhone Sales Show Stability
About EarningsIQ
EarningsIQ is a strategic reading layer on top of earnings season. We surface company performance, executive priorities, and macro signals, so investors can stay in sync without parsing transcripts.
What EarningsIQ Delivers
Actionable Insights
Distilled analysis from earnings calls that cuts through the noise and highlights what truly matters for your investment decisions.
Market Trends
Early identification of emerging sector trends and themes before they become mainstream, giving you an edge in positioning your portfolio.
Time Efficiency
Hours of research condensed into concise, mobile-friendly weekly updates that respect your time while keeping you informed.
Thematic Views
- Supply Chain Resilience: Companies Report 32% Increase in Diversification Investments
- AI Infrastructure: Global Capital Expenditures Reach $48B (+65% YoY) in Q1 2026
- Consumer Spending: Premium Segment Growth Outpaces Value as Inflation Concerns Ease
- Digital Transformation: Enterprise Software Spending Accelerates Across All Sectors
- Sustainability: ESG Initiatives Increasingly Tied to Operational Efficiency Gains
Why Earnings Intelligence Matters
In today's fast-moving markets, the signals that drive tomorrow's price movements are often hidden in today's earnings calls.
Quarterly earnings calls provide the earliest indicators of business momentum shifts, often weeks before they appear in technical charts.
Management commentary offers invaluable forward guidance that helps you anticipate market movements rather than react to them.
Our focused analysis helps you separate meaningful signals from market noise, enabling more confident investment decisions.